BEATRIZ QUINTANS

Dr. BEATRIZ QUINTANS


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 August 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
Anxo Manuel Minguillón PereiroAnxo Manuel Minguillón Pereiro
Anxo Manuel Minguillón Pereiro
BQBEATRIZ QUINTANS
BEATRIZ QUINTANS
Alberto OuroAlberto Ouro
Alberto Ouro
JVJosé Manuel Aldrey Vázquez
José Manuel Aldrey Vázquez
JHJulia Cortés Hernández
Julia Cortés Hernández
JPJuan Manuel Pias Peleteiro
Juan Manuel Pias Peleteiro
Background: Monogenic Alzheimer’s disease (AD) has severe health and socioeconomic repercussions. Its rarest cause is presenilin 2 (PSEN2) gene mutations. We present two new cases with presumed PSEN2-AD with unusual clinical and neuroimaging findings in order to provide more information on the pathophysiology and semiology of these patients. Methods: Women aged 69 and 62 years at clinical onset, marked by prominent behavioral and language dysfunction, progressing to severe dementia within three years were included. The complete study is depicted. In addition, a systematic review of the PSEN2-AD was performed. Results: Neuroimaging revealed pronounced frontal white matter hyperintensities (WMH) and frontotemporal atrophy/hypometabolism. The genetic study unveiled PSEN2 variants: c.772G>A (p.Ala258Thr) and c.1073-2_1073-1del. Both cerebrospinal fluid (CSF) and experimental blood biomarkers shouldered AD etiology. Conclusions: Prominent behavioral and language dysfunction suggesting frontotemporal dementia (FTD) may be underestimated in the literature as a clinical picture in PSEN2 mutations. Thus, it may be reasonable to include PSEN2 in genetic panels when suspecting FTDL. PSEN2 mutations may cause striking WMH, arguably related to myelin disruption induced by amyloid accumulation.

30 July 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
Anxo Manuel Minguillón PereiroAnxo Manuel Minguillón Pereiro
Anxo Manuel Minguillón Pereiro
BQBEATRIZ QUINTANS
BEATRIZ QUINTANS
Alberto OuroAlberto Ouro
Alberto Ouro
JVJose Manuel Aldrey Vazquez
Jose Manuel Aldrey Vazquez
JHJulia Cortes Hernandez
Julia Cortes Hernandez
JPJuan Manuel Pias Peleteiro
Juan Manuel Pias Peleteiro
Background: Monogenic Alzheimer's disease (AD) has severe health and socioeconomic repercussions. Its rarest cause are presenilin 2 (PSEN2) gene mutations. We present two new cases with presumed PSEN2-AD, with unusual clinical and neuroimaging findings in order to provide more information on the pathophysiology and semiology of these patients. Methods: Women aged 69 and 62 years at clinical onset, marked by prominent behavioral and language dysfunction, progressing to severe dementia within three years. Neuroimaging, laboratory study, genetic testing. In addition, a systematic review of the PSEN2-AD were performed. Results: Neuroimaging revealed pronounced frontal white matter hyperintensities (WMH) and frontotemporal atrophy/hypometabolism. The genetic study unveiled PSEN2 variants: c.772G>A (p.Ala258Thr) and c.1073-2_1073-1del. Both cerebrospinal fluid (CSF) and experimental blood biomarkers shouldered AD etiology. Conclusions: Prominent behavioral and language dysfunction suggesting frontotemporal dementia (FTD) may be underestimated in the literature as a clinical picture in PSEN2 mutations. Thus, it may be reasonable to include PSEN2 in genetic panels when suspecting FTDL. PSEN2 mutations may cause striking WMH, arguably related with myelin disruption induced by amyloid accumulation.